A fresh safety alert issued by the Food and Drug Administration in American, over a popular and widely prescribed drug for type 2 diabetics, indicates an increased risk of heart attacks and death from cardiovascular disease amongst patients taking it. The warning was prompted following a report in the New England Journal of Medicine .
The problem is by no means small, with an estimated 1 million diabetic patients taking Avandia as part of their healthcare routine. The FDA advised patients to discuss their risk of heart problems with their doctors .
An expert at the heart of the study which prompted the warning, Dr. Curt Furberg, a drug-safety professional at Wake Forest University, reportedly commented: “When I look at the totality [of the findings], there’s enough for me to pull it.”
Avandia is made by GlaxoSmithKline, one of the major global pharmaceutical corporations. They instantly attacked incomplete data, on a drug that generated $2.8 billion in sales last year.
The implications are wider, with Furberg commenting that this: “represents a major failure of the drug-use and drug-approval process in the United States.”

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…

Coronavirus: UK instructed to stay at home this weekend

Health Secretary Matt Hancock has said that staying at home this weekend…

Conversation about doctors’ appointments occurring virtually rumbles on

More than half of GP appointments are still being delivered remotely in…